Resolution of secondary pulmonary alveolar proteinosis following treatment of rhinocerebral aspergillosis

Int J Infect Dis. 2010 Sep:14 Suppl 3:e246-9. doi: 10.1016/j.ijid.2009.10.004. Epub 2010 Feb 1.

Abstract

Pulmonary alveolar proteinosis can be secondary to inhaled dust exposure, malignancy, and chronic pulmonary infections. However, pulmonary alveolar proteinosis secondary to extrapulmonary aspergillosis has never been reported. We report herein a case of pulmonary alveolar proteinosis secondary to invasive rhinocerebral aspergillosis. Neither immune modulators nor whole lung lavage was applied during the treatment course. The severe respiratory distress subsided, hypoxia resolved, and radiological infiltrates improved following the successful treatment of invasive rhinocerebral aspergillosis alone.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Neuroaspergillosis / complications*
  • Neuroaspergillosis / diagnosis
  • Neuroaspergillosis / therapy
  • Pulmonary Alveolar Proteinosis / diagnosis
  • Pulmonary Alveolar Proteinosis / etiology*
  • Pyrimidines / therapeutic use
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Triazoles / therapeutic use
  • Voriconazole

Substances

  • Antifungal Agents
  • Pyrimidines
  • Triazoles
  • liposomal amphotericin B
  • Amphotericin B
  • Voriconazole